UPDATE: Cantor Fitzgerald On Aesthetic Medical Intl Expects Co. 'to benefit from same-store growth and the addition of new facilities. For 2019, we estimate revenue growth of 28% from the 2018 level'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · 11/19/2019 17:31